1. Home
  2. ALLO vs CLMB Comparison

ALLO vs CLMB Comparison

Compare ALLO & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.32

Market Cap

539.4M

Sector

Health Care

ML Signal

HOLD

CLMB

Climb Global Solutions Inc.

HOLD

Current Price

$21.16

Market Cap

436.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
CLMB
Founded
2017
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
539.4M
436.8M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
ALLO
CLMB
Price
$2.32
$21.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
2
Target Price
$8.35
$80.00
AVG Volume (30 Days)
14.4M
121.6K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
0.60%
EPS Growth
34.09
14.29
EPS
N/A
4.64
Revenue
N/A
$652,517,000.00
Revenue This Year
N/A
$7.82
Revenue Next Year
$142,416.42
$5.83
P/E Ratio
N/A
$4.57
Revenue Growth
N/A
40.14
52 Week Low
$0.86
$19.16
52 Week High
$4.46
$145.00

Technical Indicators

Market Signals
Indicator
ALLO
CLMB
Relative Strength Index (RSI) 47.27 15.74
Support Level $1.92 $19.16
Resistance Level $2.71 $23.60
Average True Range (ATR) 0.35 0.95
MACD -0.04 2.75
Stochastic Oscillator 17.82 13.80

Price Performance

Historical Comparison
ALLO
CLMB

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

Share on Social Networks: